ClearPoint Neuro, Inc.
CLPT
$12.56
-$0.62-4.70%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.39M | 30.43M | 28.07M | 26.16M | 23.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.39M | 30.43M | 28.07M | 26.16M | 23.96M |
| Cost of Revenue | 12.27M | 12.06M | 11.27M | 11.22M | 10.34M |
| Gross Profit | 19.12M | 18.37M | 16.80M | 14.94M | 13.61M |
| SG&A Expenses | 26.48M | 25.51M | 24.55M | 24.59M | 24.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.14M | 49.28M | 46.64M | 47.13M | 46.40M |
| Operating Income | -19.75M | -18.85M | -18.57M | -20.97M | -22.45M |
| Income Before Tax | -18.91M | -18.15M | -17.98M | -20.63M | -22.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.91 | -18.15 | -17.98 | -20.63 | -22.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.91M | -18.15M | -17.98M | -20.63M | -22.09M |
| EBIT | -19.75M | -18.85M | -18.57M | -20.97M | -22.45M |
| EBITDA | -18.77M | -17.93M | -17.76M | -20.23M | -21.82M |
| EPS Basic | -0.70 | -0.69 | -0.71 | -0.83 | -0.90 |
| Normalized Basic EPS | -0.44 | -0.43 | -0.44 | -0.52 | -0.56 |
| EPS Diluted | -0.70 | -0.69 | -0.71 | -0.83 | -0.90 |
| Normalized Diluted EPS | -0.44 | -0.43 | -0.44 | -0.52 | -0.56 |
| Average Basic Shares Outstanding | 108.10M | 105.14M | 102.17M | 99.29M | 98.42M |
| Average Diluted Shares Outstanding | 108.10M | 105.14M | 102.17M | 99.29M | 98.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
